No.

Mean

SD

OS (median) (months)

p-value

DFS (median) (months)

p-value

Age

<56 years

41

13

2

32.567

0.039

25.000

0.785

>56 years

45

12.9

1.9

15.900

20.000

Gender

Male

75

13.1

1.9

26.567

0.000

9.584

0.066

Female

11

11.7

1.8

11.433

9.545

Performance at presentation

1

73

13.1

1.9

26.567

0.002

20.000

0.120

2

12

11.9

1.9

11.567

-

Treatment

RT

34

13.4

1.6

24.567

0.907

20.200

0.731

CCRT

31

12.8

2.1

18.667

17.200

RT dose

<66

45

12.8

1.8

24.567

0.569

-

0.131

>66

20

13.6

1.9

26.567

20.200

Surgery

Yes

36

13.1

1.9

25.000

0.059

20.000

0.724

No

44

12.8

2

14.700

13.200

Grade

1

14

13.5

1.9

36.571

0.155

30.946

0.306

2

61

12.9

2

22.175

20.685

3

11

12.6

1.9

22.447

20.028

T-stage

1, 2

37

13.5

2

28.790

0.554

26.621

0.299

3, 4

49

12.5

1.8

23.530

20.940

N-stage

0

51

13.2

1.9

28.290

0.031

25.228

0.647

1

35

12.6

1.9

18.227

17.824

M

0

83

13

2

23.592

0.365

22.048

0.735

1

3

13

0.8

27.522

23.889

AJCC stage

1, 2

3, 4

27

59

14.01

12.48

1.7

1.9

32.019

23.004

0.297

33.64

20.15

0.085

Pre-RT/CRT Hb level

<12

4

9.9

1.9

11.433

0.000

11.292

0.233

<13

31

11.4

1.3

26.567

8.150

>12

8

12.8

0.5

11.567

8.925

>13

43

14.4

1.1

32.567

10.571